Smallest formed element, fragments of large cells called megakaryocytic, lack nuclei, very short-lived (5-9 days), clot blood with several other chemicals and fibrinogen, release serotonin that stimulates vasoconstriction
Hematopoiesis (hemopoiesis)
1. Hematopoietic stem cells give rise to all blood cells
2. Process occurs in myeloid tissue (red bone marrow) and lymphoid tissue
3. As cells differentiate, they develop membrane receptors for chemical signals
Erythropoiesis
1. Formation of red blood cells
2. Red bone marrow produces about 2.5 million RBCs/sec
3. Process stimulated by erythropoietin from the kidneys that respond to low blood O2 levels
4. Process takes about 3 days
Hematocrit (Hct) Test
Measures the percentage of red blood cells in the blood
Leukopoiesis
1. Formation of white blood cells
2. Cytokines stimulate the production of the different subtypes
ABO system
Antigens on erythrocyte cell surfaces (Type A has A antigen, Type B has B antigen, Type AB has both A and B antigens, Type O has neither A nor B antigen)
Plasma antibodies in ABO system
Type A has anti-B antibodies, Type B has anti-A antibodies, Type AB has no antibodies (universal recipient), Type O has anti-A and anti-B antibodies (universal donor)
Rh system
Rh-positive blood has Rh factor antigen present in RBCs, Rh-negative blood has no Rh factor present in RBCs and no anti-Rh antibodies present naturally in plasma
Erythroblastosis fetalis
Hemolytic anemia that may occur when the blood types of a mother and baby are incompatible, more likely to occur during a second or subsequent pregnancy, or following a miscarriage or abortion
All Rh-negative mothers who carry an Rh-positive baby should be treated with an immunoglobulin (antibody) serum (RhoGAM)
A person with Rh-negative blood who receives a transfusion of Rh-positive blood will also develop anti-Rh antibodies and be at risk of an immune reaction if exposed to Rh-positive blood again later
Combined ABO-Rh system
Both the ABO and Rh systems are often used in combination to identify a person's blood type
Intact endothelium
Secretes prostacyclin and nitric oxide, which vasodilate and inhibit platelet aggregation, and CD39 (vascular nucleoside), which inhibit platelet aggregation further
Blood clotting
1. Clotting factors released at the injury site produce prothrombin activator
2. Prothrombin activator and calcium convert prothrombin to thrombin
3. Thrombin reacts with fibrinogen and triggers formation of fibrin, which traps RBCs to form a clot
Thrombus
When a clot stays in the place it has formed, condition is called thrombosis
Embolus
When a part of a clot dislodges and circulates through the bloodstream, condition is called embolism